Top healthcare trends to watch in 2019

Katherine Shagoury

December 31, 2018

Cannabidiol

Cannabidiol (CBD) or CBD oil is no stranger in the integrative healthcare industry. However, with benefits from reducing anxiety to easing chronic pain, it’s safe to say CBD oil is here to stay.

This past June, the U.S. Food and Drug Administration (FDA) approved the first CBD drug to treat rare, severe forms of epilepsy. And with the passing of the 2018 Farm Bill, Congress essentially legalized hemp production with overwhelming support, opening new possibilities and the likelihood that CBD could be legalized or regulated by the FDA for prescription use.

CBD will likely have a big presence on the national political stage, but in patient practice regulation and acceptance are sure to make it easier for practitioners to incorporate in patient protocols.

About the Author:

Katherine Shagoury

Katherine Shagoury

Katherine Shagoury is the editor of Integrative Practitioner. She brings a decade of experience creating and managing content for national healthcare audiences as a digital editor and professional journalist, including serving as managing editor for a popular medical billing and coding association and as a reporter for the Boston Globe, Boston.com, and USA Today. A certified personal trainer and nutrition coach with the National Academy of Sports Medicine, a certified group fitness instructor with the Athletics and Fitness Association of America, a certified barre instructor, and a TRX qualified trainer, her passion for and commitment to healthy living fuels her enthusiasm for supporting the integrative healthcare community.

© 2024 Diversified Communications. All rights reserved.
Diversified Communications